Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Disturbance in attention, Dizziness, Extra dose administered, Impaired driving ability
Clinical narrative: Felt Oozy after the 3rd dose; Could not concentrate after the 3rd dose/Could not concentrate to drive safely after the 3rd dose; Could not drive after the 3rd dose/Could not concentrate to drive safely after the 3rd dose; Body pain after the 3rd dose; Fever on & off after the 3rd dose; Fever 100F for 2 days after the 3rd dose; Extra dose; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt Oozy after the 3rd dose), DISTURBANCE IN ATTENTION (Could not concentrate after the 3rd dose/Could not concentrate to drive safely after the 3rd dose), IMPAIRED DRIVING ABILITY (Could not drive after the 3rd dose/Could not concentrate to drive safely after the 3rd dose), MYALGIA (Body pain after the 3rd dose) and PYREXIA (Fever on & off after the 3rd dose) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 9339901, 027620A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Oct-2021, the patient experienced PYREXIA (Fever 100F for 2 days after the 3rd dose) and EXTRA DOSE ADMINISTERED (Extra dose). On 07-Oct-2021, the patient experienced PYREXIA (Fever on & off after the 3rd dose). On 12-Oct-2021, the patient experienced DIZZINESS (Felt Oozy after the 3rd dose), DISTURBANCE IN ATTENTION (Could not concentrate after the 3rd dose/Could not concentrate to drive safely after the 3rd dose), IMPAIRED DRIVING ABILITY (Could not drive after the 3rd dose/Could not concentrate to drive safely after the 3rd dose) and MYALGIA (Body pain after the 3rd dose). The patient was treated with IBUPROFEN on 04-Oct-2021 for Fever, at an unspecified dose and frequency. On 04-Oct-2021, EXTRA DOSE ADMINISTERED (Extra dose) had resolved. On 06-Oct-2021, PYREXIA (Fever 100F for 2 days after the 3rd dose) had resolved. At the time of the report, DIZZINESS (Felt Oozy after the 3rd dose), DISTURBANCE IN ATTENTION (Could not concentrate after the 3rd dose/Could not concentrate to drive safely after the 3rd dose), IMPAIRED DRIVING ABILITY (Could not drive after the 3rd dose/Could not concentrate to drive safely after the 3rd dose) and MYALGIA (Body pain after the 3rd dose) outcome was unknown and PYREXIA (Fever on & off after the 3rd dose) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Oct-2021, Body temperature: 100f (High) Fever-100F.   No concomitant medications were provided.  Patient has reported that she has concern regarding administration of booster/third dose by the nurse though she was not a immunocompromised patient.